NUMD (Nu-Med Plus) Shiller PE Ratio: (As of Aug. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nu-Med Plus Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Nu-Med Plus  (OTCPK:NUMD) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Nu-Med Plus Shiller PE Ratio Related Terms


Nu-Med Plus Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Nu-Med Plus's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nu-Med Plus Shiller PE Ratio Chart

Nu-Med Plus Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nu-Med Plus Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NUMD vs AEMD, AMIX, ESMC: Shiller PE Ratio Comparison

For the Medical Devices subindustry, Nu-Med Plus's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nu-Med Plus Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nu-Med Plus's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Nu-Med Plus's Shiller PE Ratio falls into.



Nu-Med Plus Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Nu-Med Plus's E10 for the quarter that ended in Mar. 2026 is calculated as:

For example, Nu-Med Plus's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0/330.2130*330.2130
=0.000

Current CPI (Mar. 2026) = 330.2130.

Nu-Med Plus Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201606 -0.010 241.018 -0.014
201609 -0.020 241.428 -0.027
201612 -0.020 241.432 -0.027
201703 0.110 243.801 0.149
201706 -0.003 244.955 -0.004
201709 -0.004 246.819 -0.005
201712 0.000 246.524 0.000
201803 -0.004 249.554 -0.005
201806 -0.005 251.989 -0.007
201809 -0.010 252.439 -0.013
201812 -0.010 251.233 -0.013
201903 -0.010 254.202 -0.013
201906 -0.005 256.143 -0.006
201909 -0.003 256.759 -0.004
201912 0.000 256.974 0.000
202003 -0.003 258.115 -0.004
202006 -0.020 257.797 -0.026
202009 -0.010 260.280 -0.013
202012 -0.010 260.474 -0.013
202103 -0.005 264.877 -0.006
202106 -0.003 271.696 -0.004
202109 -0.001 274.310 -0.001
202112 0.000 278.802 0.000
202203 -0.001 287.504 -0.001
202206 -0.001 296.311 -0.001
202209 -0.001 296.808 -0.001
202212 0.001 296.797 0.001
202303 0.000 301.836 0.000
202306 0.000 305.109 0.000
202309 0.000 307.789 0.000
202312 0.001 306.746 0.001
202403 0.000 312.332 0.000
202406 0.000 314.175 0.000
202409 0.000 315.301 0.000
202412 0.000 315.605 0.000
202503 0.000 319.799 0.000
202506 0.000 322.561 0.000
202509 0.000 324.800 0.000
202512 0.000 324.054 0.000
202603 0.000 330.213 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nu-Med Plus Business Description

Address 640 Belle Terre Road, Building 2 E Port, Jefferson, NY, USA, 11777
Nu-Med Plus Inc is a medical device company engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and selective later-stage quality medical devices. It focuses on the formulation of Nitric Oxide powder, which is a desktop generator device which delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a mobile rechargeable device to deliver inhaled Nitric Oxide gas to offer solutions to hospitals, health systems, and the medical community throughout the world. It is currently working to locate a merger partner that will be able to fund the final development of these products.